Literature DB >> 16870793

First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America.

Maria Virginia Villegas1, Karen Lolans, Adriana Correa, Carlos Jose Suarez, Jaime A Lopez, Marta Vallejo, John P Quinn.   

Abstract

The plasmid-mediated class A carbapenemase KPC-2 was isolated from unrelated Klebsiella pneumoniae isolates in Medellin, Colombia. These KPC enzymes are the first from South America and the second isolation outside of the United States. The expanding geographic spread of KPC carbapenemases underscores the importance of clinical recognition of these enzymes.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16870793      PMCID： PMC1538657          DOI： 10.1128/AAC.00186-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  22 in total

Review 1.  Emerging carbapenemases in Gram-negative aerobes.

Authors:  P Nordmann; L Poirel
Journal:  Clin Microbiol Infect       Date:  2002-06       Impact factor: 8.067

2.  Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases: prevalence of CTX-M-3 at a hospital in China.

Authors:  Hui Wang; Swathi Kelkar; Weiyuan Wu; Minjun Chen; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

3.  Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.

Authors:  H Yigit; A M Queenan; G J Anderson; A Domenech-Sanchez; J W Biddle; C D Steward; S Alberti; K Bush; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

4.  Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center.

Authors:  P E Coudron; E S Moland; K S Thomson
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

5.  Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates.

Authors:  Ellen Smith Moland; Nancy D Hanson; Vicki L Herrera; Jennifer A Black; Thomas J Lockhart; Ashfaque Hossain; Judith A Johnson; Richard V Goering; Kenneth S Thomson
Journal:  J Antimicrob Chemother       Date:  2003-03       Impact factor: 5.790

6.  Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals.

Authors:  Maria Virginia Villegas; Adriana Correa; Federico Perez; Maria Consuelo Miranda; Tania Zuluaga; John P Quinn
Journal:  Diagn Microbiol Infect Dis       Date:  2004-07       Impact factor: 2.803

7.  Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City.

Authors:  Patricia A Bradford; Simona Bratu; Carl Urban; Melissa Visalli; Noriel Mariano; David Landman; James J Rahal; Steven Brooks; Sanda Cebular; John Quale
Journal:  Clin Infect Dis       Date:  2004-06-14       Impact factor: 9.079

8.  Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2.

Authors:  Hesna Yigit; Anne Marie Queenan; J Kamile Rasheed; James W Biddle; Antonio Domenech-Sanchez; Sebastian Alberti; Karen Bush; Fred C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

9.  Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli.

Authors:  R Odeh; S Kelkar; A M Hujer; R A Bonomo; P C Schreckenberger; J P Quinn
Journal:  Clin Infect Dis       Date:  2002-06-24       Impact factor: 9.079

10.  Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2.

Authors:  Vivi Miriagou; Leonidas S Tzouvelekis; Shannon Rossiter; Eva Tzelepi; Frederick J Angulo; Jean M Whichard
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191
View more
  80 in total

1.  A pilot survey of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae mediated by K pneumoniae serine carbapenemases in a regional referral hospital in British Columbia.

Authors:  Aubrey Shannon; Ken Wagner; Naowarat Cheeptham; Gwen Stephens
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

2.  Complete nucleotide sequence of KPC-3-encoding plasmid pKpQIL in the epidemic Klebsiella pneumoniae sequence type 258.

Authors:  Azita Leavitt; Inna Chmelnitsky; Yehuda Carmeli; Shiri Navon-Venezia
Journal:  Antimicrob Agents Chemother       Date:  2010-08-09       Impact factor: 5.191

3.  Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China.

Authors:  Ze-Qing Wei; Xiao-Xing Du; Yun-Song Yu; Ping Shen; Ya-Gang Chen; Lan-Juan Li
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

4.  First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.

Authors:  Maria Virginia Villegas; Karen Lolans; Adriana Correa; Juan Nicolas Kattan; Jaime A Lopez; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2007-01-29       Impact factor: 5.191

5.  Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of a conjugative plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 gene.

Authors:  Rodrigo E Mendes; Jan M Bell; John D Turnidge; Qiwen Yang; Yunsong Yu; Ziyong Sun; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

Review 6.  Clinical and economic impact of common multidrug-resistant gram-negative bacilli.

Authors:  Christian G Giske; Dominique L Monnet; Otto Cars; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

Review 7.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

8.  Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase.

Authors:  Krisztina M Papp-Wallace; Christopher R Bethel; Anne M Distler; Courtney Kasuboski; Magdalena Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

9.  Dynamics of bla KPC-2 Dissemination from Non-CG258 Klebsiella pneumoniae to Other Enterobacterales via IncN Plasmids in an Area of High Endemicity.

Authors:  Ana M Rada; Elsa De La Cadena; Carlos Agudelo; Cesar Capataz; Nataly Orozco; Cristian Pallares; An Q Dinh; Diana Panesso; Rafael Ríos; Lorena Diaz; Adriana Correa; Blake M Hanson; Maria V Villegas; Cesar A Arias; Eliana Restrepo
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

10.  Detection of the Klebsiella pneumoniae carbapenemase type 2 Carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid.

Authors:  J Kamile Rasheed; James W Biddle; Karen F Anderson; Laraine Washer; Carol Chenoweth; John Perrin; Duane W Newton; Jean B Patel
Journal:  J Clin Microbiol       Date:  2008-04-02       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.